Skip to main content
Nasheed Hossain, MD, Hematology, Philadelphia, PA

Nasheed Mohammad Hossain MD

Hematologic Oncology


Physician

Join to View Full Profile
  • 3400 Spruce StPhiladelphia, PA 19104

  • Phone+1 215-615-0063

  • Fax+1 215-349-8144

Dr. Hossain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Temple University Hospital-Fox Chase Cancer Center
    Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 2010 - 2013
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2010

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2013 - 2026
  • CA State Medical License
    CA State Medical License 2016 - 2025
  • IL State Medical License
    IL State Medical License 2018 - 2023
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-...
    Nasheed Hossain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)
    Nasheed Hossain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • ‘Exciting’ Research Spotlights CAR-t’s Evolving Role in Blood Cancer Treatment
    ‘Exciting’ Research Spotlights CAR-t’s Evolving Role in Blood Cancer TreatmentFebruary 22nd, 2023
  • Graft Versus Host Disease Research
    Graft Versus Host Disease ResearchJune 17th, 2023
  • Research into Graft Versus Host Disease (GVHD)
    Research into Graft Versus Host Disease (GVHD)June 28th, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: